Symbol Lookup from Yahoo Finance

Trending Tickers

Symbol	Name	Last Price	Change	Change %
PLTR	Palantir Technologies Inc.	65.34	+0.99	+1.54%
SAVA	Cassava Sciences, Inc.	4.1500	-22.3300	-84.33%
TSLA	Tesla, Inc.	348.76	-3.80	-1.08%
M	Macy's Inc	15.77	-0.53	-3.23%
QMCO	Quantum Corporation	20.92	+11.79	+129.13%
ZM	Zoom Video Communications, Inc.	91.25	+5.37	+6.25%
RGTI	Rigetti Computing, Inc.	3.1100	+1.3700	+78.74%
HOOD	Robinhood Markets, Inc.	38.43	+1.78	+4.86%
AMC	AMC Entertainment Holdings, Inc	4.7948	+0.2448	+5.38%
BBWI	Bath & Body Works, Inc.	35.95	+5.24	+17.06%
KULR	KULR Technology Group, Inc.	0.6722	+0.2271	+51.01%
BBIO	BridgeBio Pharma, Inc.	30.32	+6.90	+29.46%
QMMM	QMMM Holdings Limited	1.1100	+0.3601	+48.02%
RKLB	Rocket Lab USA, Inc.	23.61	+0.35	+1.49%
OPEN	Opendoor Technologies Inc	2.3001	+0.3101	+15.52%
PDYN	Palladyne AI Corp.	5.02	+0.42	+9.13%
WLDS	Wearable Devices Ltd.	2.6322	+0.7522	+40.01%
ALAB	Astera Labs, Inc.	112.53	+10.25	+10.01%
SRRK	Scholar Rock Holding Corporatio	39.40	+9.48	+31.68%
VSTE	Vast Renewables Limited	2.1450	+0.4950	+30.00%
QS	QuantumScape Corporation	5.44	+0.28	+5.42%
MRNA	Moderna, Inc.	44.84	+3.73	+9.06%
HIMS	Hims & Hers Health, Inc.	28.88	+3.55	+14.00%
INTC	Intel Corporation	25.26	+0.76	+3.10%
QBTS	D-Wave Quantum Inc.	3.2050	+0.2750	+9.37%

Related News

Anglo American, Sony, Rocket Lab: 3 Stocks in Focus

Anglo American (AAL.L) reaches an agreement with Peabody Energy (BTU) to sell its steel-making coal business in a deal valued up to $3.1 billion. Sony (SONY) reportedly plans to make a handheld console to rival the Nintendo (NTDOY) Switch, according to reports from Bloomberg. Rocket Lab USA (RKLB) completes two space launches successfully within 24 hours, setting a company record for the fastest turnaround between missions. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Naomi Buchanan.

Yahoo Finance Video 2 minutes ago

AGPPF

ANGPY
Tesla rally is sentiment-driven, not on fundamental strength: UBS

Tesla (TSLA) shares extend their rally catalyzed by President-elect Donald Trump's reelection after CEO Elon Musk's support of the former President's campaign earned him a proposed Cabinet nomination. Seana Smith and Brad Smith take a closer look at the stock move as UBS analysts warn the electric vehicle maker's jump is driven by animal spirits rather than actual positive fundamentals. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Naomi Buchanan.

Yahoo Finance Video 47 minutes ago

TSLA
Stocks rise as Wall Street cheers Trump’s Treasury pick: Yahoo Finance

The Dow Jones Industrial Average (^DJI), S&P 500 (^GSPC), and Nasdaq Composite (^IXIC) are all trading higher after President-elect Donald Trump announced he is going to nominate hedge fund manager Scott Bessent to be his Treasury secretary. Investors will be eyeing retail earnings this week, with Kohl’s (KSS), Abercrombie & Fitch (ANF), and Best Buy (BBY) set to report. Trending tickers on Yahoo Finance include Tesla (TSLA), Palantir Technologies (PLTR), and Rocket Lab (RKLB). Key guests include:9:10 a.m. ET - Stacey Widlitz, SW Retail Advisors President9:25 a.m. ET - Ed Mills, Raymond James Washington Policy Analyst10:10 a.m. ET - Jason Furman, Harvard Kennedy School of Government11:15 a.m. ET - Matt Christopherson, NAR Director of Business & Consumer Research11:35 a.m. ET - Jean Chatzky, HerMoney CEO and co-founder

Yahoo Finance Video 3 hours ago

M
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops

Cassava Sciences stock plummeted Monday after the company's Alzheimer's treatment failed in Phase 3 testing.

Investor's Business Daily 10 minutes ago

SAVA

SAVAW
Magnificent Seven Stocks: Nvidia Stock Sells Off; Tesla Reverses From New Highs

Nvidia stock sold off Monday, falling further from last week's record highs, while Tesla reversed from new highs.

Investor's Business Daily 18 minutes ago

NVDA

AAPL
Cassava Sciences Stock Slides 84% as Alzheimer’s Trial Fails

The treatment didn’t show a significant reduction in cognitive or functional decline compared with a placebo.

Barrons.com 27 minutes ago

SAVAW
Intel rises 2% on report of $8 billion Chips Act grant

Investing.com -- Intel Corporation (NASDAQ:INTC) shares rose 2% in premarket trading Monday following a CNBC report that the chipmaker was nearing a deal with the U.S. Commerce Department for a nearly $8 billion grant under the Chips Act, according to sources familiar with the matter.

Investing.com 40 minutes ago

INTC
Macy’s Stock Is Falling. Earnings Are Being Delayed by an Accounting Issue.

A now former Macy’s employee hid as much as $154 million of delivery expenses from 2021 through 2024. An investigation is underway.

Barrons.com 41 minutes ago

M
Palantir Stock Can Get Another AI Boost, Analyst Says. These Stocks Can Surge, Too.

After Nvidia’s roaring success in recent years it may be time for the wider software sector to ‘get in on the AI party.’ That’s the view of Wedbush analysts.

Barrons.com 44 minutes ago

PLTR
Robinhood raised to overweight at Morgan Stanley; PT $55

Investing.com -- Morgan Stanley (NYSE:MS) analysts have upgraded Robinhood (NASDAQ:HOOD) stock to Overweight from Equal Weight on Monday, and more than doubled their price target from $24 to $55.

Investing.com 47 minutes ago

HOOD
Elon Musk says he's a friend of the environment. But Tesla's factories are racking up pollution violations

Tesla’s (TSLA) pollution issues have reportedly gone unaddressed at its Texas headquarters, adding another link in Elon Musk’s lengthy chain of environmental problems caused by his companies’ factories.

Quartz 50 minutes ago

TSLA
These Stocks Are Moving the Most Today: Super Micro, Snowflake, Palantir, MicroStrategy, Robinhood, Macy’s, Cassava, and More

Shares of Super Micro Computer extend last week’s sharp gains, Snowflake stock is upgraded, and MicroStrategy buys more Bitcoin.

Barrons.com 50 minutes ago

SMCI

MSTR
BridgeBio Soars After Drug Gets Nod in Rare Heart Condition

(Bloomberg) -- BridgeBio Pharma Inc. jumped the most in 16 months after its drug got US regulators’ nod to treat a rare, deadly form of heart disease, paving the way for head-to-head competition with medications from Pfizer Inc.Most Read from BloombergNYC's Underground Steam System May Be Key to a Greener FutureIn Kansas City, a First-Ever Stadium Designed for Women’s Sports Takes the FieldNew York City’s ‘Living Breakwaters’ Brace for Stormier SeasNYC Gets Historic Push for 80,000 Homes With $5

Bloomberg 53 minutes ago

BBIO

PFE
US cuts Intel’s federal chips grant to below $8bn amid new deal

The reduction in funds is said to be linked to Intel’s delay in completing an Ohio chip manufacturing facility.

Verdict 59 minutes ago

INTC
Macy's Battles Back: Q3 Gains Marred by $154M Accounting Scandal Ahead of Holiday Season

Early sales growth sparks hope, but a $154M bookkeeping fiasco leaves investors uneasy ahead of December's full report.

GuruFocus.com 1 hour ago

M
Jump in Tesla stock mostly driven by 'animal spirits/momentum' says UBS

Investing.com -- Tesla’s recent stock surge of approximately 40% since the U.S. election is being driven more by investor sentiment than fundamental changes, according to UBS analysts on Monday.

Investing.com 1 hour ago

TSLA
Robinhood Gets 129% Target Hike As 'Animal Spirits Revive'

Robinhood stock popped on an upgrade. Analyst sees more potential revenue growth in the wake of U.S. elections, business expansion.

Investor's Business Daily 1 hour ago

SCHW

HOOD
Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies

Cassava Sciences Inc. (NASDAQ:SAVA) stock plunged Monday after the company released topline data from the Phase 3 ReThink-ALZ study of simufilam in mild-to-moderate Alzheimer’s disease. The trial did not meet the pre-specified co-primary, secondary, and exploratory biomarker endpoints. In July, CEO Rick Barry wrote a letter to shareholders and employees, saying that the company is in the final stages of testing simufilam and has significant financial and emotional stakes. The co-primary endpoint

Benzinga 1 hour ago

SAVAW
Palantir's 300% Surge: AI Titan or Overvalued Hype Machine?

Insider sales, jaw-dropping valuations, and soaring growth--what's next for this AI powerhouse?

GuruFocus.com 1 hour ago

PLTR
Cassava Stock Plunges as Alzheimer's Drug Fails Late-Stage Study

Cassava Sciences shares are plunging in premarket trading and are losing most of their value after the biotech firm said its experimental Simufilam drug aimed at treating Alzheimer’s disease failed to show a “significant reduction in cognitive or functional decline” during the Phase 3 trial of the treatment.

Investopedia 1 hour ago

SAVAW

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Trending Tickers

Related News

Anglo American, Sony, Rocket Lab: 3 Stocks in Focus

Tesla rally is sentiment-driven, not on fundamental strength: UBS

Stocks rise as Wall Street cheers Trump’s Treasury pick: Yahoo Finance

Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops

Magnificent Seven Stocks: Nvidia Stock Sells Off; Tesla Reverses From New Highs

Cassava Sciences Stock Slides 84% as Alzheimer’s Trial Fails

Intel rises 2% on report of $8 billion Chips Act grant

Macy’s Stock Is Falling. Earnings Are Being Delayed by an Accounting Issue.

Palantir Stock Can Get Another AI Boost, Analyst Says. These Stocks Can Surge, Too.

Robinhood raised to overweight at Morgan Stanley; PT $55

Elon Musk says he's a friend of the environment. But Tesla's factories are racking up pollution violations

These Stocks Are Moving the Most Today: Super Micro, Snowflake, Palantir, MicroStrategy, Robinhood, Macy’s, Cassava, and More

BridgeBio Soars After Drug Gets Nod in Rare Heart Condition

US cuts Intel’s federal chips grant to below $8bn amid new deal

Macy's Battles Back: Q3 Gains Marred by $154M Accounting Scandal Ahead of Holiday Season

Jump in Tesla stock mostly driven by 'animal spirits/momentum' says UBS

Robinhood Gets 129% Target Hike As 'Animal Spirits Revive'

Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies

Palantir's 300% Surge: AI Titan or Overvalued Hype Machine?

Cassava Stock Plunges as Alzheimer's Drug Fails Late-Stage Study